홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Tetrahydrofuran → N-(9-fluorenylmethoxycarbonyl)-O-(4,4-bis(diethylphosphoryl)butyl)-L-tyrosine

HRID 39268
인쇄

반응식

HRID 39268 반응식
[CH:1]1[C:13]2[CH:12]([CH2:14][O:15][C:16]([NH:18][C@H:19]([C:28]([OH:30])=[O:29])[CH2:20][C:21]3[CH:26]=[CH:25][C:24]([OH:27])=[CH:23][CH:22]=3)=[O:17])[C:11]3[C:6](=[CH:7][CH:8]=[CH:9][CH:10]=3)[C:5]=2[CH:4]=[CH:3][CH:2]=1.C1C=[CH:35][C:34]([P:37]([C:44]2[CH:49]=[CH:48][CH:47]=CC=2)[C:38]2[CH:43]=CC=CC=2)=CC=1.N(C(O[CH:61]([CH3:63])C)=O)=NC(OC(C)C)=O.CC[O:66][P:67](OCC)([CH:69](P(OCC)(OCC)=O)[CH2:70]CCO)=O.C1C[O:88]CC1>>[CH:1]1[C:13]2[CH:12]([CH2:14][O:15][C:16]([NH:18][C@H:19]([C:28]([OH:30])=[O:29])[CH2:20][C:21]3[CH:22]=[CH:23][C:24]([O:27][CH2:47][CH2:48][CH2:49][CH:44]([P:37]([CH2:34][CH3:35])([CH2:38][CH3:43])=[O:88])[P:67]([CH2:61][CH3:63])([CH2:69][CH3:70])=[O:66])=[CH:25][CH:26]=3)=[O:17])[C:11]3[C:6](=[CH:7][CH:8]=[CH:9][CH:10]=3)[C:5]=2[CH:4]=[CH:3][CH:2]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

6

반응물 5

HCID 8028Tetrahydrofuran2회HCID 11776TriphenylphosphineHCID 75555Diisopropyl diazene-1,2-dicarboxylateHCID 6957986(2S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-hydroxyphenyl)propanoic acidHCID 153967034,4-Bis(Diethoxyphosphoryl)butan-1-ol

생성물 1

HCID 86762026
N-(9-fluorenylmethoxycarbonyl)-O-(4,4-bis(diethylphosphoryl)butyl)-L-tyrosine
수율 43%

실험 절차

A solution of 83 (664 mg, 1.44 mmol) and PPh3 (454 mg, 1.73 mmol) in THF (20 mL) was cooled in an ice-bath followed by the addition of diisopropyl azodicarboxylate (336 mg, 1.74 mmol). After a further 10 min a solution of 81 (500 mg, 1.44 mmol) in THF (5 mL) was added and the resulting solution was stirred while warming to room temperature overnight. The solvent was removed at reduced pressure and the crude material was purified by silica gel chromatography (0 to 10% methanol in ethyl acetate over 10 column volumes then 10 to 20% over 5 column volumes) using a Biotage Horizon™ apparatus resulting in the colourless liquid 84 (491 mg, 43%): 1H NMR (400 MHz, CDCl3) δ 1.33 (t, J=7.1, 6H), 1.34 (t, J=7.1, 6H), 1.43 (s, 9H), 2.04-2.18 (m, 4H), 2.37 (tt, J=6.3, 24.2, 1H), 2.98-3.07 (m, 2H), 3.92 (t, J=5.8, 2H), 4.14-4.22 (m, 8H), 4.33 (dd, J=7.1, 10.4, 1H), 4.43 (dd, J=7.2, 10.5, 1H), 4.50 (dd, J=6.0, 8.4, 1H), 5.24, (d, J=8.1, 1H), 6.78 (d, J=8.5, 2H), 7.04 (d, J=8.4, 2H), 7.28-7.33 (m, 2H), 7.40 (t, J=7.6, 2H), 7.77 (d, J=7.6, 2H): 31P (162 MHz, CDCl3) δ 24.74 (s, 2P).

후처리

  1. customThe solvent was removed at reduced pressure
  2. customthe crude material was purified by silica gel chromatography (0 to 10% methanol in ethyl acetate over 10 column volumes

출처 및 근거

ORD 기록
ord-25c6d1d1a7234f55a4c27f12923f8b3f
출처 데이터셋
uspto-grants-2013_09
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08524691B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트